WHO Register of non-State actors

Disclaimer:

Information regarding a non-State actor, contained in the section “Non-State Actors Profiles” in the Register, has been provided by that non-State actor itself, and the accuracy and completeness of such information is the sole responsibility of that non-State actor, not WHO. In turn, information in the sections “WHO’s Engagement” and “Non-State Actors in Official Relations” has been provided by WHO, subject to certain conditions. All access and use of any section of the Register is governed by the Terms and Conditions of Use.

Overview

Official name

RAD-AID International, Inc.

Acronym (if applicable)

Short self description

RAD-AID began in 2008 to answer the epidemiologic need for medical imaging technology in resource-limited parts of the world. The organization has grown to include more than 11,000 volunteers from 100 countries, 45,000 web visitors per year, 75 university-based chapter organizations, a radiologist representative in Geneva, on-site programs in 31 countries, and an annual conference on global health radiology.

Medical imaging constitutes part of nearly every segment of healthcare including (e.g.) the management and control of: cardiovascular disease, oncology, chronic respiratory diseases, pediatrics, obstetrics, gynecology, trauma, surgery, multiple infectious diseases (such as TB), and complications of diabetes. Following evidence-based guidelines and best practices, the current shortage of global radiology remains a critical puzzle piece to address in reducing global healthcare disparities.

Website

http://www.rad-aid.org

Web link to health relevant activities

Parent entity (if applicable)

The entity you represent is indicated as a parent of the following entities in the Register:

N / A

Date submitted

07 Nov 2023 01:23:27 AM

General information

Name

Official name

RAD-AID International, Inc.

Acronym (if applicable)

Commonly used name (if applicable)

RAD-AID

Names in other official languages (if applicable) Name Abbreviation

RAD-AID International

RAD-AID

Former name

Short self description

Address

Address 1

8004 Ellingson Drive

Address 2

Address 3

Town/City

Chevy Chase

State/Region

Postal code

20815

Country

United States of America

Related links

Website

http://www.rad-aid.org

Governance

Legal status

non-profit organization

Year established

2008

Governance structure

Description of main decision making bodies (e.g. board, board of directors, executive board, executive committee, etc).

Name of body

Board of Directors

Composition and current list of members Name Function Affiliation

Daniel Mollura, MD

Board Chair; President

RAD-AID International

Sonnie Dockser

Board Director

President, Dockser Family Foundation

Theresa Loar

Board Director

Senior Vice President of International Programs, CH2M

Alyse Nelson

Board Director

Chief Executive Officer, Vital Voices Global Partnership

Issack Boru

Board Director

Imaging Services Manager, Duke University

Geoffrey Rubin

Board Director

Professor & Chair of Medical Imaging, University of Arizona

Michelle Starikovsky Fuentealba

Board Director

Vice President, Clarion Partners

Liana Watson

Board Director

ABII Coordinator, American Registry of Radiologic Technologists

David Youmans

Board Director

Radiologist, Princeton Radiology

Farouk Dako

Board Director

Assistant Professor, University of Pennsylvania

Geraldine McGinty

Board of Director

Senior Associate Dean for Clinical Affairs, Weill Cornell Medicine

Functions

The Board of Directors at RAD-AID supervises the organization's strategic development and oversees the appointment of RAD-AID management officers. The Board also ensures the financial accountability of the organization including ethics, enforcement of conflict-of-interest policy, and legal compliance.

Name of body

Governance Committee

Composition and current list of members Name Function Affiliation

Anne-Marie Lugossy

Vice President

RAD-AID International

Sara Rike

Secretary

RAD-AID International

Lauren Fuller

Treasurer

RAD-AID International

Functions

The Governance Committee is responsible for operational planning and implementation of RAD-AID programs, including project logistics, outcomes measurement, partnership-planning, and communications with in-country collaborators.

General Assembly

Does the entity have a General Assembly of members or a similar body?

Yes

Name

Composition

Functions

Financial information

Latest available annual income (month/year)

From

January

2022

December

2022

Annual income (USD)

3,843,964

Latest available assets (month/year)

As of

December

2022

Total assets (USD)

11,735,561

Income sources (in USD)

Income source Income type

Private sector entities (including business associations)

Philanthropic foundations

NGOs, academic institutions

Government entities, intergovernmental organizations, including UN

General public, individuals

Total

Sales of goods and services *

Grants / Donations

1,197,327

292,864

1,490,191

In-kind donations

2,350,909

Membership fees

5,800

Investment income

Others

Total

1,197,327

5,800

2,643,773

3,846,900

* income from congresses / conferences should be listed under Sales of goods and services

Additional information

For 2022 - we reported investment (loss) income (2936). I am unable to enter a negative number in the table above. Please advise

FOR THE YEAR ENDED DECEMBER 31, 2022, RAD-AID HAS DOCUMENTED ITS
CONSIDERATION OF FASB ASC 740-10, INCOME TAXES, THAT PROVIDES GUIDANCE FOR
REPORTING UNCERTAINTY IN INCOME TAXES, AND HAS DETERMINED THAT NO MATERIAL
UNCERTAIN TAX POSITIONS QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN
THE FINANCIAL STATEMENTS.

Membership

Entity's members

Is the entity you represent membership based?

Yes

Overview of categories and their voting rights in the main governing body:

Total number Voting

Individuals

NGOs

Private sector entities

Philanthropic foundations

Academic institutions

Government entities

Intergovernmental organizations

Organizational Structure

Parent entity

In the register Registered Entity Entity Name

No data available

Yes

Legal status

Affiliated entities (or subsidiaries)

In the register Registered Entity Entity Name

No data available

Relations

Entity's membership in other entities

In the register Registered Entity Entity Name Type of membership

No data available

Members of the entity

In the register Registered Entity Member Name

No data available

Activities

Aims (or purposes, objectives) of the entity as they appear in its constitution or by-laws or equivalent document.

RAD-AID International is a nonprofit organization organized exclusively for charitable and scientific purposes, to build a global network for assisting the developing world in achieving better access to medical imaging and radiology services. These functions are performed on a nondiscriminatory and interdenominational basis and not restricted to people of any race, faith, color or creed. Source: Article 2 Section 2 of RAD-AID International's Bylaws and Section 3 of RAD-AID International's Certificate of Incorporation (State of Delaware and in accordance with Section 501c3 of US Internal Revenue Code and laws of United States).

The activities of the entity are related to the following strategic priorities and outcomes of the current WHO's General Programme of Work:

Strategic Priority 1: One billion more people benefiting from universal health coverage

Outcome 1.1 - improved access to quality essential health services

Outcome 1.2 - reduced number of people suffering financial hardships

Outcome 1.3 - improved access to essential medicines, vaccines, diagnostics and devices for primary health care

Strategic Priority 2: One billion more people better protected from health emergencies

Outcome 2.1 - countries prepared for health emergencies

Outcome 2.2 - epidemics and pandemics prevented

Outcome 2.3 - health emergencies rapidly detected and responded to

Strategic Priority 3: One billion more people enjoying better health and well-being

Outcome 3.1 - determinants of health addressed

Outcome 3.2 - risk factors reduced through multisectoral action

Outcome 3.3 - healthy settings and Health in All Policies promoted

Strategic Priority 4: More effective and efficient WHO providing better support to countries

Outcome 4.1 - strengthened country capacity in data and innovation

Additional information on the entity's activities

RAD-AID International focuses on increasing human capacity and on strengthening local economies to improve and optimize access to medical imaging and related diagnostics. This mission aligns to support the strategic priorities of the World Health Organization's General Programme of Work.

Country presence

Countries where the entity has activities, members and regional offices / representatives:

Regions

Countries

Activities

Members

Offices / representatives

African Region

Region of the Americas

Eastern Mediterranean Region

European Region

South-East Asia Region

Western Pacific Region

Global

Disclosure & declaration

Tobacco/Arms related disclosure statement for non-State actors

Pursuant the WHO Framework of Engagement with Non-State Actors, WHO does not engage with the tobacco industry or non-State actors that work to further the interests of the tobacco industry. WHO also does not engage with the arms industry.

For the purposes of this statement:

tobacco industry means any entity involved in the manufacture, sale or distribution of tobacco and related products, and any affiliate of such entity; and
arms industry means any entity involved in the manufacture, sale or distribution of arms, and any affiliate of such entity.

This disclosure statement needs to be provided by any nongovernmental organization, private sector entity, philanthropic foundation and academic institution prior to engaging with WHO.

In view of the foregoing, please answer the following questions:

Is your entity, or was your entity over the last four years, part of the tobacco or arms industries (as defined above)?

Yes

No

Unable to answer

To the best of your entity’s knowledge, is your entity, or has your entity over the last four years, engaged in activities that are aimed at furthering or supporting the interests of the tobacco industry? This includes, but is not limited to, supply contracts, contract work, services and lobbying.

Yes

No

Unable to answer

To the best of your entity’s knowledge, does your entity currently, or did your entity over the last four years, have any other association or relationship with the tobacco industry (as defined above). This includes in particular investment interests (other than general mutual funds or similar arrangements whereby your entity has no control over the selection of the investments), commercial business interests, the provision or receipt of financial and/or other support.

Yes

No

Unable to answer

If you have answered yes to any of the above or are unable to answer one or more questions, please provide a general statement of explanation.

Please note that the WHO Secretariat reserves the right to request additional information from your entity in this regard.

By providing this statement, your entity commits to promptly inform WHO of any change to the above information and to complete a new statement that describes the changes.

Engagement with other industries affecting human health or affected by WHO norm and standards

Does the entity you represent have any formal association, affiliation or links with the following industry sectors?

If yes, please tick the box of the industry concerned and provide details in the space provided:

Alcohol

Chemical

Food and beverages

Health care

Pharmaceutical

Bayer contributed an in-kind donation of a power injector (medical device) to New Amsterdam and Bartica hospitals for use with the local CT scanner through RAD-AID to support the radiology program in Guyana. Such injectors are used to administer contrast dyes such as those listed in section 14.2 (Radiocontrast Media) of the WHO Model List of Essential Medicines. The power injector enables RAD-AID to educate local Guyanese radiology trainees and health providers to accurately diagnose and treat non-communicable diseases, like cancer and cardiovascular disease, which aligns with the WHO global target of reducing NCDs.

Others

Please specify industry

WHO Secretariat reserves the right to request additional information from the entity you represent relevant to its engagement with WHO.

*Sexual Exploitation, Abuse and Harassment (SEAH) and Misconduct (abusive or fraudulent)

Entities engaging with WHO are expected to ensure that the conduct of their employees and any other persons engaged by them to perform any activities or to provide any services for WHO on behalf of the entities is consistent with the WHO standards of conduct. In particular, WHO has zero tolerance towards any form of sexual misconduct, which includes sexual exploitation, sexual abuse, sexual violence, and sexual harassment, and other types of abusive or fraudulent conduct. In the view of the forgoing, please confirm that your entity shall:

Take all reasonable and appropriate measures to prevent sexual misconduct as defined in WHO’s Policy on Preventing and Addressing Sexual Misconduct, and other types of abusive or fraudulent conduct as defined, respectively, in WHO’s Policy on Preventing and Addressing Abusive Conduct and in WHO’s Policy on Prevention, Detection and Response to Fraud and Corruption by any of its employees and by any other persons engaged by it to perform any activities or to provide any services for WHO on the entity’s behalf;

Promptly report to WHO’s Office of Internal Oversight Services (IOS) at investigation@who.int any actual or suspected misconduct, as defined by WHO in these Policies and of which the entity becomes aware;

Promptly communicate to IOS any measures that may be necessary or appropriate to protect the confidentiality and wellbeing of the alleged victim;

Promptly respond to any actual or suspected misconduct as defined by WHO in these Policies of which the entity becomes aware; and

To cooperate with IOS and keep IOS informed of the status and outcome of any measures of protection, corrections to operations, investigation, and disciplinary action taken against any perpetrator by the entity.

Date submitted